Literature DB >> 19103918

Non-adherence to medicines: not solved but solvable.

Rachel Elliott1.   

Abstract

Non-adherence to medicines is common, with convincing evidence for adverse effects on patient health and costs to health systems. At least half of reported non-adherence is intentional. An extensive body of research suggests that, while patient characteristics may contribute to this behaviour, key influences are linked to beliefs and experiences of an illness and its medicines. Characteristics of the health system such as patient-practitioner relationships and access are also significant drivers. Inadvertent effects of some policies, such as co-payments, reduce adherence. Interventions to improve adherence have not utilized available research evidence fully and are not integrated into service delivery, so have been disappointing in producing sustained behaviour change. Policies relying on patients' adherence to medicines will not be as effective as hoped if adherence is assumed rather than supported. Substantial gains could be made by patients and health systems if patients, practitioners, researchers and policy-makers worked together to improve this crucial area of health behaviour.

Entities:  

Mesh:

Year:  2009        PMID: 19103918     DOI: 10.1258/jhsrp.2008.008088

Source DB:  PubMed          Journal:  J Health Serv Res Policy        ISSN: 1355-8196


  12 in total

Review 1.  Intentional non-adherence to medications by older adults.

Authors:  Omar Mukhtar; John Weinman; Stephen H D Jackson
Journal:  Drugs Aging       Date:  2014-03       Impact factor: 3.923

2.  The association between medication non-adherence and adverse health outcomes in ageing populations: A systematic review and meta-analysis.

Authors:  Caroline A Walsh; Caitriona Cahir; Sarah Tecklenborg; Catherine Byrne; Michael A Culbertson; Kathleen E Bennett
Journal:  Br J Clin Pharmacol       Date:  2019-09-06       Impact factor: 4.335

Review 3.  Understanding Patient Preferences in Medication Nonadherence: A Review of Stated Preference Data.

Authors:  Tracey-Lea Laba; Beverley Essue; Merel Kimman; Stephen Jan
Journal:  Patient       Date:  2015-10       Impact factor: 3.883

Review 4.  How the EMERGE guideline on medication adherence can improve the quality of clinical trials.

Authors:  Lina Eliasson; Sarah Clifford; Amy Mulick; Christina Jackson; Bernard Vrijens
Journal:  Br J Clin Pharmacol       Date:  2020-02-28       Impact factor: 4.335

Review 5.  A new taxonomy for describing and defining adherence to medications.

Authors:  Bernard Vrijens; Sabina De Geest; Dyfrig A Hughes; Kardas Przemyslaw; Jenny Demonceau; Todd Ruppar; Fabienne Dobbels; Emily Fargher; Valerie Morrison; Pawel Lewek; Michal Matyjaszczyk; Comfort Mshelia; Wendy Clyne; Jeffrey K Aronson; J Urquhart
Journal:  Br J Clin Pharmacol       Date:  2012-05       Impact factor: 4.335

Review 6.  Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review.

Authors:  Sara Garfield; Sarah Clifford; Lina Eliasson; Nick Barber; Alan Willson
Journal:  BMC Med Res Methodol       Date:  2011-11-03       Impact factor: 4.615

7.  Medicines use reviews: a potential resource or lost opportunity for general practice?

Authors:  Asam Latif; Kristian Pollock; Helen F Boardman
Journal:  BMC Fam Pract       Date:  2013-05-06       Impact factor: 2.497

8.  Developing the Diagnostic Adherence to Medication Scale (the DAMS) for use in clinical practice.

Authors:  Sara Garfield; Lina Eliasson; Sarah Clifford; Alan Willson; Nick Barber
Journal:  BMC Health Serv Res       Date:  2012-10-08       Impact factor: 2.655

9.  Development of an adherence-enhancing intervention in topical treatment termed the topical treatment optimization program (TTOP).

Authors:  Kristian Reich; Ulrich Mrowietz; Eleni Karakasili; Ina Zschocke
Journal:  Arch Dermatol Res       Date:  2014-06-04       Impact factor: 3.017

10.  Protocol for the New Medicine Service Study: a randomized controlled trial and economic evaluation with qualitative appraisal comparing the effectiveness and cost effectiveness of the New Medicine Service in community pharmacies in England.

Authors:  Matthew Boyd; Justin Waring; Nick Barber; Rajnikant Mehta; Antony Chuter; Anthony J Avery; Nde-Eshimuni Salema; James Davies; Asam Latif; Lukasz Tanajewski; Rachel A Elliott
Journal:  Trials       Date:  2013-12-01       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.